Urgent Product Correction Notification: Dexcom G6 receivers 29 January 2025 An Urgent Product Correction Notification has been issued for Dexcom G6 Continuous Glucose Monitoring (CGM) receivers. Manufacturer AMSL Diabetes says some customers of the G6 receiver may experience an issue where alerts/alarms do not function as they should. In very rare instances, the alert/alarm may be missed or delayed. Users rely on these alerts to show glucose levels that are too high or too low. If these alerts do not operate as expected, users may not receive timely notifications. The manufacturer lists identification information relating to the affected devices as (STK-GS-120 – All batches) ARTG 169241. Users are urged to take immediate action to ensure their device is functioning correctly and to avoid potential health risks. The manufacturer has outlined a series of steps for users to verify that their alerts are functioning properly. These include checking the device settings, ensuring notifications are enabled, and confirming that software updates have been installed. Additionally, users can perform regular manual glucose monitoring as a backup measure. Individuals who experience issues with their device should seek immediate help from Dexcom’s customer support team on 1300 851 056 or email [email protected] with the product serial number listed on the back.
Media releases 17 August 2026 Diabetes Australia to deliver Insulin Pump Program supporting children and young people Diabetes Australia has been appointed to deliver the Commonwealth-funded Insulin Pump Program (IPP). Continue Reading
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading